John Edward Robinson - 25 Jan 2022 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Scientific Officer
Signature
/s/ Ryan Murr, Attorney-in-Fact
Issuer symbol
COGT
Transactions as of
25 Jan 2022
Transactions value $
$1,235,800
Form type
4
Filing time
27 Jan 2022, 16:40:01 UTC
Next filing
15 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $1,235,800 +250,000 $4.94 250,000 25 Jan 2022 Common Stock 250,000 $7.6 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in equal monthly installments over a four year period.